132 related articles for article (PubMed ID: 2589847)
1. Combination effect of recombinant human interleukin-1 alpha with antimicrobial agents.
Nakamura S; Minami A; Fujimoto K; Kojima T
Antimicrob Agents Chemother; 1989 Oct; 33(10):1804-10. PubMed ID: 2589847
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha.
Minami A; Fujimoto K; Ozaki Y; Nakamura S
Infect Immun; 1988 Dec; 56(12):3116-20. PubMed ID: 3263325
[TBL] [Abstract][Full Text] [Related]
3. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.
Gudmundsson S; Einarsson S; Erlendsdottir H; Moffat J; Bayer W; Craig WA
J Antimicrob Chemother; 1993 May; 31 Suppl D():177-91. PubMed ID: 8335520
[TBL] [Abstract][Full Text] [Related]
4. [Combination effects between KW-2228 and antibiotics against systemic infections in normal and neutropenic mice].
Sato K; Yoneyama H; Yoshino T
Jpn J Antibiot; 1992 Jan; 45(1):91-7. PubMed ID: 1379652
[TBL] [Abstract][Full Text] [Related]
5. Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (rG-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone.
Matsumoto M; Matsubara S; Yokota T
J Antimicrob Chemother; 1991 Sep; 28(3):447-53. PubMed ID: 1720432
[TBL] [Abstract][Full Text] [Related]
6. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a.
Ozaki Y; Ohashi T; Minami A; Nakamura S
Infect Immun; 1987 Jun; 55(6):1436-40. PubMed ID: 3553002
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of ventriculitis caused by
Gofman N; To K; Whitman M; Garcia-Morales E
Am J Health Syst Pharm; 2018 Jul; 75(13):953-957. PubMed ID: 29941534
[TBL] [Abstract][Full Text] [Related]
8. [Combined effects of anti-Pseudomonas antibiotics with G-CSF on systemic infections by Pseudomonas aeruginosa in a leukocytopenic mouse model].
Kaneko A; Tomita F; Kobayashi I
Jpn J Antibiot; 1993 May; 46(5):364-6. PubMed ID: 7686990
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of intravenous immunoglobulin and antimicrobial agents on acute pneumonia in leukopenic mice.
Shimizu M; Katoh H; Hamaoka S; Kinoshita M; Akiyama K; Naito Y; Sawa T
J Infect Chemother; 2016 Apr; 22(4):240-7. PubMed ID: 26867796
[TBL] [Abstract][Full Text] [Related]
10. Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1.
Van't Wout JW; Van der Meer JW; Barza M; Dinarello CA
Eur J Immunol; 1988 Jul; 18(7):1143-6. PubMed ID: 3261247
[TBL] [Abstract][Full Text] [Related]
11. [Combination effect of KW-2228 and cephem antibiotics in a systemic infection model in neutropenic mice].
Yoshino T; Sato K
Jpn J Antibiot; 1992 Jan; 45(1):106-11. PubMed ID: 1379649
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice.
Kullberg BJ; van 't Wout JW; Poell RJ; van Furth R
Antimicrob Agents Chemother; 1992 Jun; 36(6):1225-9. PubMed ID: 1416821
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gut-derived sepsis with Pseudomonas aeruginosa.
Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
Cytokine; 1999 May; 11(5):366-72. PubMed ID: 10328876
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.
Iizawa Y; Okonogi K; Hayashi R; Iwahi T; Yamazaki T; Imada A
Antimicrob Agents Chemother; 1993 Jan; 37(1):100-5. PubMed ID: 8431004
[TBL] [Abstract][Full Text] [Related]
15. Moxalactam therapy for bacterial infections.
Winston DJ; Busuttil RW; Kurtz TO; Young LS
Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antimicrobial agents using an experimental pulmonary superinfection model with Aspergillus fumigatus and Pseudomonas aeruginosain leukopenic mice.
Mitsuyama J; Kizawa K; Minami S; Watanabe Y; Yamaguchi K
J Infect Chemother; 2003 Jun; 9(2):144-50. PubMed ID: 12825113
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy: a way to limit emergence of resistance?
Michéa-Hamzehpour M; Pechère JC; Marchou B; Auckenthaler R
Am J Med; 1986 Jun; 80(6B):138-42. PubMed ID: 3088999
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
[TBL] [Abstract][Full Text] [Related]
19.
Zhao M; Lepak AJ; Marchillo K; Andes DR
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332063
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
Sader HS; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
